Pre-Approval Inspection (PAI) Readiness

To date, we have had a 100% success rate on PAI Readiness projects for our clients.

Our team of experts is equipped to guide you through every step of any Inspection, especially Pre-Approval Inspections, due to the nature of their criticality.

Ensure Your Product's Path to Market with Expert PAI Support

We ensure that every step towards Inspection Readiness is carefully calibrated to your needs. Our method is backed by tangible tools and training programs developed from the ground up, tailored not just to your product, but to your organization's unique scale and scope. This approach allows you to maintain focus on running your business, while we dedicate ourselves fully to your Inspection Readiness, making it our singular priority.

Gloved worker working with beakers in a laboratory

Inspection Readiness Evaluation / Gap Assessment

Our industry experts will audit and evaluate all aspects of your organization that are vital to a filing and commercialization - Quality Management Systems (QMS), Development, Manufacturing, Laboratories, etc. Additionally, we can provide similar evaluations of your CROs, CMOs, and Testing Laboratories. It is important to note that any organization listed in the filing is subject to inspection and should prepare.

ProPharma will produce a report outlining observation criticality and recommendations to aid in remediation and optimization efforts for your firm.

Collaborative, connected, and global

Project Management

Project Management

Checkmark icon

Remediation and Optimization

Remediation and Optimization

Program and project management icon

Develop an Inspection Program or Optimize Existing Program

Develop an Inspection Program or Optimize Existing Program

Innovation icon

Training

Training

Signal management icon

Mock Inspections

Mock Inspections

Adverse event intake icon

Post-Readiness Activities

Post-Readiness Activities

Project Management

Project Management is critical to the success of every project. No example is better than the importance of Project Management for PAI Readiness. Inspection Readiness has a multitude of simultaneous and associated activities. These activities include assessments and evaluations, remediation and optimization, logistics planning and execution, training, mock inspections, etc. And, of course, there is the ever present need to conduct "business as usual" concurrently. The everyday work does not stop while a firm is getting "Inspection Ready". The Project Manager will initiate, plan, and monitor all readiness activities with quality, budget, and timeline in mind .

Business worker working around a conference table

Remediation and Optimization

As an outcome of the Inspection Readiness Evaluation or other gap assessments, remediation or optimizations efforts with respect to policies, procedures, practices, documentation, facilities, etc. will likely be required. These activities can vary in size, criticality, or effort. Teaming with ProPharma for your firm’s remediation and optimization needs puts your firm closer to the finish line on your road to filing and Inspection Readiness. We have the experience and expertise to help guide you through the activities and ensure compliance and quality are maintained throughout.

Person wearing protective equipment reviewing a tablet device

Develop an Inspection Program or Optimize Existing Program

ProPharma can create Standard Operating Procedures (SOPs) on how inspections are handled at your organization and/or vendor organization. We can implement request and response processes (paper-based or electronic). We can develop all of the tools necessary for a successful PAI. Alternatively, we can review your existing Inspection processes and optimize them as necessary.

healthcare-workers-labcoats-reviewing-papers-near-computer-monitor-ss-46716574-650x425

Training

ProPharma can provide and execute various trainings to ensure Inspection Readiness. The entire organization will be trained on why PAIs occur and what to expect. Additionally, SMEs require and benefit from training on proper interviewing skills and responses to Inspectors’ questions. And finally, the Inspection Management Team’s training on roles, responsibilities, and their deliverables to ensure a smooth inspection experience for all.

customer-service-professional-wearing-headset-asking-coworker-a-question-ss-2149603273

Mock Inspections

ProPharma has helped many organizations plan and execute Mock Inspections with utilization of our former FDA investigators as well as our industry experts. Mock Inspections help ensure that the implementation, remediation, or optimization of processes has been a worthwhile effort as well as ensuring training on Inspection behavior has been successful.

Health care professionals reviewing x-ray scans on large television

Post-Readiness Activities

  • Inspection Support: Take a role in your inspection, as a part of your Inspection Management Team
  • Response Support: ProPharma is adept with Agency responses to observations, utilizing a holistic and S.M.A.R.T. approach (Specific, Measurable, Attainable, Relevant, and Timebound)
  • Additional remediation activities support
Group of professional women talking in a lobby

ProPharma can Provide and Support Your PAI Needs

Inspection readiness, whether it be a PAI or other Regulatory Inspection, is both a mindset and a practice. ProPharma can help you get there using one or all of our full suite of Inspection Readiness offerings. From Inspection Readiness Evaluations through to supporting you onsite or remotely during your PAI, we are your partner. And as your partner, we are highly skilled, collaborative, and dynamic.

Key focus areas for PAIs are far reaching. Among the most critical are:

  • Firm's ability to produce the product as outlined in the filing, readiness for commercialization
  • Quality System in place for the control of commercial operations
  • Robust Quality Management System (QMS)
  • Oversight of third party vendors/suppliers (Supplier qualification program)
  • Data Integrity
  • Quality product development program
Two professionals reviewing details on a computer monitor

Expert-Driven Pre-Approval Inspection

ProPharma is an industry leader helping companies ensure regulatory complianceWhether it be for Project Management, Mock PAI, PAI Readiness, Inspection Response or any other Quality, Regulatory or Inspection needs, we are the company you can rely on to be your partner.  

Want to learn more about PAI and Inspection Readiness?

Pre-Approval Inspection (PAI) Readiness is Easy, Right?

Pre-Approval Inspection (PAI) Readiness is Easy, Right?

Facing a pending filing and subsequent PAI can feel overwhelming, no matter if you are a young firm or an established company. You're balancing the excitement of bringing a new product to market with...

Pre-Approval Inspection (PAI): What it is and How to Prepare

Pre-Approval Inspection (PAI): What it is and How to Prepare

What is a Pre-Approval Inspection (PAI)? A pre-approval inspection (PAI) is performed to provide the Food and Drug Administration (FDA) assurances that a manufacturing site named in a drug...

How to Ensure Your Device, Software, and Drug Are All Ready for a Pre-Approval Inspection

How to Ensure Your Device, Software, and Drug Are All Ready for a Pre-Approval Inspection

When drug or device manufacturers apply for marketing approval of a new product, the FDA may conduct a pre-approval inspection (PAI). The PAI is performed to help the Agency assure that a...

News & Insights

FDA's Shift to One Pivotal Trial for Drug Approval: Regulatory Strategy Implications for Sponsors

February 24, 2026

FDA's Shift to One Pivotal Trial for Drug Approval: Regulatory Strategy Implicat...

FDA’s shift to one pivotal trial raises global stakes. Learn how to engineer globally acceptable development programs from the start.

User Requirements for AI in GxP: Designing, Selecting, and Validating AI/ML Software with Confidence

February 23, 2026

User Requirements for AI in GxP: Designing, Selecting, and Validating AI/ML Soft...

Effective AI/ML implementation in life sciences requires clear user requirements, robust validation, and strong governance to ensure compliance and performance.

Why Medical Information Is Central to MAH Compliance, Access, and Patient Safety – Identifying Reportable Information

February 19, 2026

Why Medical Information Is Central to MAH Compliance, Access, and Patient Safety...

Learn why Medical Information is essential for MAH compliance, patient safety, and capturing reportable data, ensuring trust and proactive insights in real-world medical use.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

December 4, 2025

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Setting up a Global PV System - ProPharma

February 5, 2026

Setting up a Global PV System

A company needed to rapidly establish a fully compliant global pharmacovigilance (PV) system, including UK/EU QPPV coverage, to meet regulatory requirements by a fixed deadline. With safety data and...

Case Study High-Volume Global Pharmacovigilance Onboarding - ProPharma

January 30, 2026

High-Volume Global Pharmacovigilance Onboarding

A global biotechnology sponsor faced a sudden surge in pharmacovigilance demand, with monthly ICSR volumes exceeding 30,000 cases across multiple regions. Limited internal capacity, tight onboarding...

Case Study Stabilizing High-Volume Legal Case Processing Through Structured Governance - ProPharma

January 28, 2026

Stabilizing High-Volume Legal Case Processing Through Structured Governance

ProPharma’s client faced escalating operational risk as high-volume legal case documentation overwhelmed their prior vendor. Thousands of documents, missed regulatory timelines, and a surge of...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

March 12, 2026

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

Uncover the intricacies of Pharmacovigilance System Master File (PSMF) management and explore proven strategies to ensure inspection readiness, effective MAH oversight, and regulatory compliance...

News & Insights

FDA's Shift to One Pivotal Trial for Drug Approval: Regulatory Strategy Implications for Sponsors

February 24, 2026

FDA's Shift to One Pivotal Trial for Drug Approval: Regulatory Strategy Implicat...

FDA’s shift to one pivotal trial raises global stakes. Learn how to engineer globally acceptable development programs from the start.

User Requirements for AI in GxP: Designing, Selecting, and Validating AI/ML Software with Confidence

February 23, 2026

User Requirements for AI in GxP: Designing, Selecting, and Validating AI/ML Soft...

Effective AI/ML implementation in life sciences requires clear user requirements, robust validation, and strong governance to ensure compliance and performance.

Why Medical Information Is Central to MAH Compliance, Access, and Patient Safety – Identifying Reportable Information

February 19, 2026

Why Medical Information Is Central to MAH Compliance, Access, and Patient Safety...

Learn why Medical Information is essential for MAH compliance, patient safety, and capturing reportable data, ensuring trust and proactive insights in real-world medical use.

Previous Post Arrow Next Post Arrow
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

December 4, 2025

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Setting up a Global PV System - ProPharma

February 5, 2026

Setting up a Global PV System

A company needed to rapidly establish a fully compliant global pharmacovigilance (PV) system, including UK/EU QPPV coverage, to meet regulatory requirements by a fixed deadline. With safety data and...

Case Study High-Volume Global Pharmacovigilance Onboarding - ProPharma

January 30, 2026

High-Volume Global Pharmacovigilance Onboarding

A global biotechnology sponsor faced a sudden surge in pharmacovigilance demand, with monthly ICSR volumes exceeding 30,000 cases across multiple regions. Limited internal capacity, tight onboarding...

Case Study Stabilizing High-Volume Legal Case Processing Through Structured Governance - ProPharma

January 28, 2026

Stabilizing High-Volume Legal Case Processing Through Structured Governance

ProPharma’s client faced escalating operational risk as high-volume legal case documentation overwhelmed their prior vendor. Thousands of documents, missed regulatory timelines, and a surge of...

Previous Resource Arrow Next Resource Arrow
Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

March 12, 2026

Mastering the PSMF: The Pillar of Inspection Readiness for MAHs, LPPVs & QPPVs

Uncover the intricacies of Pharmacovigilance System Master File (PSMF) management and explore proven strategies to ensure inspection readiness, effective MAH oversight, and regulatory compliance...

Previous Webinar Arrow Next Webinar Arrow